Status:
COMPLETED
Biomarkers in Saliva in Children With Juvenil Idiopathic Arthritis
Lead Sponsor:
Folktandvården Stockholms län AB
Conditions:
Juvenile Idiopathic Arthritis
Eligibility:
All Genders
7-14 years
Brief Summary
Purpose and aims This as a pilot study that aims to investigate which inflammatory biomarkers can be found in saliva in children with Juvenile Idiopathic Arthritis (JIA). The hypothesis is that child...
Detailed Description
This is a comparison between 100 children with JIA and 100 healthy children. Saliva will be collected and analyzed with respect to biomarkers. One-hundred consecutive patients with active JIA, as dia...
Eligibility Criteria
Inclusion
- 1\. A diagnosis of JIA according to the International League of Associations for rheumatology (ILAR) The parents of the patients and/or the patients will give their verbal and written informed consent to participate in the study according to the permission from the regional ethical committee 2011/2:1
Exclusion
- current malignancies
- TMJ surgery or trauma within two years
- Recent intra-articular glucocorticoid injection in TMJ (within 1 month)
- Other conditions or diseases than JIA that may cause orofacial pain. Fore the controllgroup JIA are excluded
Key Trial Info
Start Date :
March 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02223195
Start Date
March 1 2015
End Date
October 1 2019
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Folktandvården Stockholmslän AB
Stockholm, Sweden, 17267